Search alternatives:
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
increase » increased (Expand Search)
Showing 21 - 40 results of 27,397 for search '(( significant based decrease ) OR ( significant substantial increase ))', query time: 1.15s Refine Results
  1. 21
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 22
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 23
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 24
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 25
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 26
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 27
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 28
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 29
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 30
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 31
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 32
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 33
    Substantial variation in individual patterns of voluntary alcohol consumption in outbred mice.

    Substantial variation in individual patterns of voluntary alcohol consumption in outbred mice. by Nathan Yu (2981751)

    Published 2025
    Save to List
    Saved in:
  14. 34
    Statistically significant union pathways refer to the miRNAs with an increased expression on day 5.

    Statistically significant union pathways refer to the miRNAs with an increased expression on day 5. by Morgana Lüdtke Azevedo (15285409)

    Published 2023
    Save to List
    Saved in:
  15. 35
    Statistically significant union pathways refer to the miRNAs with an increased expression on day 1.

    Statistically significant union pathways refer to the miRNAs with an increased expression on day 1. by Morgana Lüdtke Azevedo (15285409)

    Published 2023
    Save to List
    Saved in:
  16. 36
    Comparison of the cohesion ranges of different food categories under IDDSI levels.

    Comparison of the cohesion ranges of different food categories under IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 37
    Relationships between cohesiveness and IDDSI levels.

    Relationships between cohesiveness and IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 38
    Relationships between adhesiveness and IDDSI levels.

    Relationships between adhesiveness and IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 39
    Comparison of adhesiveness ranges for different food categories under IDDSI levels.

    Comparison of adhesiveness ranges for different food categories under IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 40
    Cohesiveness changes across IDDSI levels and food categories.

    Cohesiveness changes across IDDSI levels and food categories. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: